TrialDiabetes, obesity & metabolism2020

Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.

Nienke M A Idzerda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.